SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-067718
Filing Date
2018-11-13
Accepted
2018-11-13 07:31:18
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19018_110q.htm 10-Q 960162
2 EX-31.1 a18-19018_1ex31d1.htm EX-31.1 12840
3 EX-31.2 a18-19018_1ex31d2.htm EX-31.2 12704
4 EX-32.1 a18-19018_1ex32d1.htm EX-32.1 6853
  Complete submission text file 0001104659-18-067718.txt   3990439

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20180930.xml EX-101.INS 746637
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20180930.xsd EX-101.SCH 38155
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20180930_cal.xml EX-101.CAL 40633
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20180930_lab.xml EX-101.LAB 341278
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20180930_pre.xml EX-101.PRE 235174
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20180930_def.xml EX-101.DEF 109972
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 181175116
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1